Bacitracin vs Polymyxin B — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Bacitracin is a polycyclic peptide antibiotic from Bacillus subtilis licheniformis, first isolated in 1945 from wound cultures of a 7-year-old girl named Margaret Tracy (hence "bacitracin"). It is available OTC in Neosporin and similar triple-antibiotic ointments and is one of th...
Calculate Bacitracin dose →Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →| Parameter | Bacitracin | Polymyxin B |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved (topical) | FDA Approved |
| Half-Life | Hours (topical) | 6-8 hours |
| Typical Dose | 400-500 units/g ointment | 15,000-25,000 units/kg/day IV |
| Frequency | 1-3x daily | Every 12 hours IV |
| Route | Topical | IV / IM / Topical / Intrathecal |
| FDA Status | Approved (topical) | Approved (systemic Gram-negative infections) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.